Functional studies of the interleukin 2 receptor (IL-2R) of two (ED515-D and Kit225) IL-2-dependent and three (ED515-I, 3T3-alpha beta 11, and Hut102) IL-2-independent cell lines were done. All of these cell lines appeared to express high as well as low affinity IL-2R. However, ED515-I and 3T3-alpha beta 11, which expressed the IL-2R beta chain, did not bind IL-2 at all when IL-2 binding to their IL-2R alpha chain was blocked with anti-Tac monoclonal antibody, whereas the intermediate affinity binding in ED515-D, Kit225, and Hut102 cells remained. We tentatively called the high affinity IL-2R of the former cells pseudo-high affinity IL-2R. The dissociation constant of pseudo-high affinity IL-2R was higher than that of ordinary high affinity IL-2R. Internalization of cell-bound 125I-IL-2 into ED515-I and 3T3-alpha beta 11 cells was less efficient than that into ED515-D cells. The addition of IL-2 neither promoted cell growth nor upregulated IL-2R alpha chain expression in ED515-I and 3T3-alpha beta 11 cells. Furthermore, tyrosine phosphorylation of the cellular proteins (p120, p98, p96, p54, and p38) was induced or enhanced in response to the addition of IL-2 in ED515-D and Kit225 cells, but not in the cell lines expressing pseudo-high affinity IL-2R. Finally, 125I-IL-2 crosslinking followed by SDS-PAGE analysis showed an 80-kD band corresponding to p65 + IL-2, in addition to bands corresponding to IL-2R alpha and beta chain + IL-2 in cells bearing ordinary high affinity IL-2R but not in cells with pseudo-high affinity IL-2R. Taken together, we consider that another protein whose molecular mass is approximately 65 kD is functionally important in IL-2 binding and subsequent signal transduction and may be the third component of IL-2R.
Skip Nav Destination
Article navigation
1 November 1992
Article|
November 01 1992
Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.
N Arima,
N Arima
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
M Kamio,
M Kamio
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
K Imada,
K Imada
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
T Hori,
T Hori
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
T Hattori,
T Hattori
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
M Tsudo,
M Tsudo
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
M Okuma,
M Okuma
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
T Uchiyama
T Uchiyama
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Search for other works by this author on:
N Arima
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
M Kamio
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
K Imada
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
T Hori
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
T Hattori
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
M Tsudo
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
M Okuma
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
T Uchiyama
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1992) 176 (5): 1265–1272.
Citation
N Arima, M Kamio, K Imada, T Hori, T Hattori, M Tsudo, M Okuma, T Uchiyama; Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.. J Exp Med 1 November 1992; 176 (5): 1265–1272. doi: https://doi.org/10.1084/jem.176.5.1265
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement